Immunophotonics is pioneering the field of Interventional Immunology-Oncology™, where a single injection of IP-001 --seamlessly integrated into the clinical workflow--...

Immunophotonics co-founders Lu Alleruzzo (CEO), Tomas Hode, PhD (CIO and President), and David Anderson, PhD (CSO) are excited to be...

Immunophotonics won the Startup World Cup St. Louis Regional finals. A big thank you to Emily Hemingway and her team...

We are thrilled to announce that Dr. Robert Martin has successfully enrolled and treated the first patient in our groundbreaking...

Immunophotonics is excited to share that Wei Chen, co-inventor of IP-001, Stephenson Chair, professor and interim director of the Stephenson...

Immunophotonics is excited to be featured in Pharma Tech Outlook magazine in the Immunotherapy edition.  Immunophotonics innovative approach could transform...

Immunophotonics is excited to announce that a leading academic medical center that combines high-quality complex patient care with innovative scientific...

Lu Alleruzzo, CEO, Tomas Hode, PhD, CIO, and President, along with the Immunophotonics Team, extend their congratulations to Professor Wei...

Immunophotonics is excited to share that Dr. Robert CG Martin II, M.D, PhD, PACS, who serves as Principal Investigator and...

Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be in Chicago at the ASCO (American...